Real-Time PCR And Digital PCR Market Size And Forecast

Real-Time PCR And Digital PCR Market size was valued at USD 4.85 Billion in 2020 and is projected to reach USD 9.37 Billion by 2028, growing at a CAGR of 8.6% from 2021 to 2028.

Increase in the incidence of infectious diseases and genetic disorders, as well as an increase in the number of diagnostic centers and hospitals, are driving the market growth. Additionally, increased public-private investments to increase illness diagnostics awareness and technologically sophisticated product introductions are propelling the Global Real-Time PCR And Digital PCR Market forward. The Global Real-Time PCR And Digital PCR Market report provide a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Real-Time PCR And Digital PCR Market Definition

The polymerase chain reaction (PCR) is a typical method for amplifying small DNA or RNA segments.DNA cloning, diagnosis of hereditary disorders, functional analysis of genes, paternity testing, detection of infectious diseases, and forensic sciences are all applications of polymerase chain reaction (PCR) technology. Digital Polymerase Chain Reaction (PCR), real-time PCR, and traditional PCR are among the many forms of PCR available on the market. Real-time PCR uses molecular markers to estimate the amount of amplified DNA in a given amount of time. Real-time PCR, also known as quantitative PCR (qPCR), While qPCR does not require post-amplification processing, the analytical process is faster and the possibility of contamination of amplified DNA or RNA is reduced., whereas digital PCR uses a method of detecting and measuring very sensitive nucleic acids.

Digital PCR is a molecular counting-based technology for DNA amplification and quantification that is still relatively new. Digital PCR is most commonly used to distinguish allele expression, trace viral infection to individual bacterial cells, quantify cancer genes, and detect fetal DNA in the bloodstream. The main benefit of dPCR is that it is unaffected by reaction efficiency and does not require the use of standard curves. These cutting-edge methods enable scientists to deal with DNA and RNA amplification in a simple yet effective manner. An increase in the number of research and forensic laboratories has assisted the growth of the Real-Time PCR And Digital PCR Market.

Get | Download Sample Report @ https://www.verifiedmarketresearch.com/download-sample/?rid=1432&utm_source=Free&utm_medium=004

Global Real-Time PCR And Digital PCR Market Overview

The Global Real-Time PCR And Digital PCR Market are predicted to be driven by an increase in the incidence of infectious diseases and genetic disorders, as well as an increase in the number of diagnostic centers and hospitals. The use of genomic analysis tools in the diagnosis of major infectious diseases (such as HIV, TB, malaria, and hepatitis) and genetic abnormalities has increased substantially over the last decade (such as cancer). The rising global frequency of target diseases, together with the shown efficacy of qPCR and dPCR analysis in the diagnosis and estimation of disease-causing microorganisms, will raise the adoption of clinical diagnostic tests (including qPCR and dPCR analysis) and drive market expansion.

The expansion of healthcare infrastructure, an increase in healthcare expenditure, and lower procedural costs for qPCR and dPCR-based illness diagnostics are all driving these markets forward. The growing healthcare infrastructure in emerging countries is accompanied by the rapid upgrading of healthcare facilities. This aspect is contributing to diagnostic laboratories’ increasing demand for clinical diagnostic procedures, which is leading to higher sales of clinical qPCR and dPCR products. Furthermore, increased public-private investments to increase illness diagnostics awareness and technologically sophisticated product introductions are propelling the Global Real-Time PCR And Digital PCR Market forward.

However, the high cost of instruments connected with dPCR and limitations in dPCR and qPCR procedures are projected to restrain the Global Real-Time PCR And Digital PCR Market growth. To reach the intended process output, a typical PCR analysis performed using dPCR devices combines various scientific technologies (PCR, microfluidics, and nanofabrication). These instruments are compact, with short cycle times. However, the development of such instruments necessitates huge economic inputs as well as extensive nanoscale scientific validation. Furthermore, owing to the rising frequency of infectious and chronic diseases, as well as increased R&D initiatives to develop innovative genomic techniques such as qPCR and dPCR, emerging markets are likely to offer significant growth opportunities.

Global Real-Time PCR And Digital PCR Market: Segmentation Analysis

The Global Real-Time PCR And Digital PCR Market is Segmented Based on Technology, Application, Products and Services, End User, And Geography.

Real-Time PCR And Digital PCR Market, By Technology

• Quantitative PCR (qPCR)
• Digital PCR (dPCR)

Based on Technology, the market is segmented into Quantitative PCR (qPCR) and Digital PCR (dPCR). Digital PCR is expected to increase at a 9.3% CAGR. Owing to expanding uses of the technology in cancer/tumor investigations, prenatal diagnostics, and gene expression studies, this segment is expected to increase at the fastest rate. The Digital PCR markets were dominated by quantitative PCR. This rise is likely to continue in the forecast period owing to the wide range of applications and scope in Medical Biotechnology.

Ask For Report Details @ https://www.verifiedmarketresearch.com/product/global-real-time-pcr-and-digital-pcr-market-size-and-forecast-to-2025/?utm_source=Free&utm_medium=004

Real-Time PCR And Digital PCR Market, By Application

• Industry Applications
• Agriculture Biotechnology
• Applied sciences
• Clinical Diagnostics
• Others

Based on Application, the market is segmented into Industry Applications, Agriculture Biotechnology, Applied sciences, Clinical Diagnostics, and Others. In 2016, industry applications accounted for two-thirds of the market for Real-Time PCR and Digital PCR. The segment is expected to rise at an 8.9% compound annual growth rate (CAGR) owing to the enhanced use of GMOs in the consumption sector and for determining the zygosity of transgenic animals employed in research, as well as during GMO-based insulin manufacture.

Real-Time PCR And Digital PCR Market, By  End User

• Pharmaceutical & Biotech Companies
• Clinical Research Organizations
• Hospitals And Laboratories
• Other End Users

Based on End User, the market is segmented into Pharmaceutical & Biotech Companies, Clinical Research Organizations, Hospitals And Laboratories, and Other. Owing to the rising market availability of qPCR reagents in clinical research organizations, the ongoing expansion of healthcare infrastructure across emerging countries, high prevalence and incidence of target diseases such as cancer, HIV-AIDS, malaria, and tuberculosis, and growing awareness among end-users about the benefits offered by qPCR in rapid and effective disease diagnosis, the Hospitals and Laboratories segment dominated this market in 2019.

Real-Time PCR And Digital PCR Market, By Products & Services

• Instruments
• Reagents and Consumables
• Software and Services

Based on Products & Services, the market is segmented into instruments, Reagents and Consumables, and Software and Services. The market is dominated by the instruments category, followed by reagents and consumables, and software and services. The software & services category is expected to grow at the fastest pace of 9.9% during the forecast period, owing to its widespread use in the pharmaceutical and biotech healthcare industries, where genetic model-based research is now growing rapidly, which acts as a market driver.

Real-Time PCR And Digital PCR Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

On the basis of Geography, the Global Real-Time PCR And Digital PCR Market are classified into North America, Europe, Asia Pacific, and the Rest of the world. North America accounted for more than half of the global market. The Asia-Pacific region is expected to grow at the fastest rate. This is attributed to an increase in illness prevalence and the number of HIV, Hepatitis, viral infections including helicobacter pylori infection, and cancer cases.

• In 2020: Thermo Fisher Scientific, Inc acquired an emergency use authorization (EUA) from the US FDA for its SARSCoV2 multiplex real-time PCR test.

• In 2020: Roche Diagnostics acquired FDA 510k clearance for the cobas BKV test.

• In 2019: The US FDA approved Bio-Rad Laboratories, Inc.’s QXDxAutoDGddPCR System and the QXDx BCR-ABL percent IS Kit.

Key Players

The “Global Real-Time PCR And Digital PCR Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as Roche Ltd, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories, Qiagen N.V, Takara Bio, Inc, Agilent Technologies, Inc., BioMerieux SA, Danaher Corporation and Merck KGaA.

For More Information @ https://www.verifiedmarketresearch.com/download-sample/?rid=1432&utm_source=Free&utm_medium=004

About us –

Verified Market Research is a leading Global Research and Consulting firm that has been providing advanced analytical research solutions, custom consulting and in-depth data analysis for 10+ years to individuals and companies alike that are looking for accurate, reliable and up to date research data and technical consulting. VMR offers insights into strategic and growth analyses, Data necessary to achieve corporate goals and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities and optimize efficiency by working as their partner to deliver accurate and valuable information. The industries we cover span over a large spectrum including Technology, Chemicals, Manufacturing, Energy, Food and Beverages, Automotive, Robotics, Packaging, Construction, Mining & Gas. Etc.

We, at Verified Market Research assist in understanding holistic market indicating factors and most current and future market trends. Our analysts, with their high expertise in data gathering and governance, utilize industry techniques to collate and examine data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject expertise and years of collective experience to produce informative and accurate research.

Having serviced over 5000+ clients, we have provided reliable market research services to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms like McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for businesses worldwide.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research

US: +1 (650)-781-4080

UK: +44 (753)-715-0008

APAC: +61 (488)-85-9400

US Toll-Free: +1 (800)-782-1768

Website:-https://www.verifiedmarketresearch.com/

Email: [email protected]

Try Our New Dashboard :-https://www.verifiedmarketresearch.com/dashboard/?utm_source=Free&utm_medium=004